Read the following publication: Rosenfeld, R. M., Piccirillo, J. F., Chandrasekhar, S. S., Brook, I., Ashok Kumar, K., Kramper, M., … Corrigan, M. D. (2015). Clinical practice guideline (update): adult sinusitis. Otolaryngology–Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 152(2 Suppl), S1–S39.
1.
Define and classify acute, subacute, chronic and recurrent rhinosinusitis.
2.
What are the predisposing factors for rhinosinusitis?
3.
Discuss the presentation and management differences between viral and bacterial sinusitis.
4.
Describe the microbiology of acute bacterial rhinosinusitis and resistance patterns.
5.
Discuss antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
6.
Discuss the role of culture-directed therapy in acute rhinosinusitis.
Reference(s):
Smith, S. S., Ference, E. H., Evans, C. T., Tan, B. K., Kern, R. C., & Chandra, R. K. (2015). The prevalence of bacterial infection in acute rhinosinusitis: a Systematic review and meta-analysis. The Laryngoscope, 125(1), 57–69.
7.
What is the role of allergies in the development of acute rhinosinusitis vs. chronic sinusitis?
Reference(s):
Pant, H., Ferguson, B. J., & Macardle, P. J. (2009). The role of allergy in rhinosinusitis. Current Opinion in Otolaryngology & Head and Neck Surgery, 17(3), 232–238.
8.
List the potential extracranial and intracranial complications of sinusitis.
9.
What is the Chandler classification?
10.
What are the different stages of a brain abscess?
11.
Discuss the pathogenesis and treatment of Potts puffy tumor.
12.
Discuss the role of placebo in terms of antibiotic therapy for acute sinusitis.
Reference(s):
Rosenfeld, R. M., Piccirillo, J. F., Chandrasekhar, S. S., Brook, I., Ashok Kumar, K., Kramper, M., … Corrigan, M. D. (2015). Clinical practice guideline (update): adult sinusitis. Otolaryngology–Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 152(2 Suppl), S1–S39.
13.
Discuss the role of anticoagulation in cavernous sinus thrombosis.
Reference(s):
Smith, D. M., Vossough, A., Vorona, G. A., Beslow, L. A., Ichord, R. N., & Licht, D. J. (2015). Pediatric cavernous sinus thrombosis: A case series and review of the literature. Neurology, 85(9), 763–769.
14.
In which patients with subperiosteal abscesses can medical therapy be tried first?
Reference(s):
Liao, J. C., & Harris, G. J. (2015). Subperiosteal abscess of the orbit: evolving pathogens and the therapeutic protocol. Ophthalmology, 122(3), 639–647.
15.
What is the Lund McCay score? How is it used in terms of predicting treatment success for sinus disease?
Reference(s):
Hopkins, C., Browne, J. P., Slack, R., Lund, V., & Brown, P. (2007). The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngology–Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 137(4), 555–561.
16.
Discuss the role of oral steroids in sinus disease. What are the potential side effects that you should tell your patients?